Abstract
AbstractInterspecies interactions involving direct competition via bacteriocin production play a vital role in shaping ecological dynamics within microbial ecosystems. For instance, the ribosomally-produced siderophore bacteriocins, known as class IIb microcins, have been observed to affect the colonization of pathogenicEnterobacteriaceaespecies within hosts. Notably, to date, only five of these antimicrobials have been identified and all were derived from specificEscherichia coliandKlebsiella pneumoniaestrains. We hypothesized that class IIb microcin production extends beyond these specific compounds and organisms. By employing an informatics-driven approach, screening bacterial genomes in publicly accessible databases, we have discovered a total of twelve previously unknown class IIb microcins. Our investigation unveiled that these microcins are harbored within a diverse array ofEnterobacteriaceaespecies, encompassing phytopathogens and environmental isolates. We introduce three novel clades of microcins (MccW, MccX, and MccZ), while also identifying eight new variants of the five previously known ones. To validate their antimicrobial potential, we heterologously expressed these microcins, along with their immunity peptides, inE. coliand unequivocally demonstrated their efficacy against a variety of bacterial isolates, including plant pathogens likeGibbsiellaspeciesand Rahnella victoriana. Remarkably, two of these newly discovered class IIb microcins exhibit activity against gram-negative ESKAPE pathogens, such asAcinetobacter baumanniiorPseudomonas aeruginosaproviding the first evidence that class IIb microcins can target bacteria outside of theEnterobacteriaceaefamily. Our findings hold significant promise for the development of innovative live biotherapeutic products tailored to combat these resilient bacteria and underscore the notion that class IIb microcins are more prevalent and more broad-spectrum in the natural microbial world than previously recognized.
Publisher
Cold Spring Harbor Laboratory